Sara Sande
Director/Board Member bij EXPRES2ION BIOTECH HOLDING AB
Profiel
Sara Sande is currently the Director at Biosyntia ApS.
She is also serving as an Independent Director at Expres2ion Biotech Holding AB and as the Vice President at Origio A.
Previously, she worked as an Independent Director at Hydract A, Head-Grain & Beverages Sales at Novozymes A, and Vice President-Global Commercial Development at CooperSurgical, Inc. Ms. Sande completed her graduate degree at the University of Copenhagen in 2002.
Actieve functies van Sara Sande
Bedrijven | Functie | Begin |
---|---|---|
EXPRES2ION BIOTECH HOLDING AB | Director/Board Member | 26-05-2021 |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Corporate Officer/Principal | - |
Biosyntia ApS
Biosyntia ApS BiotechnologyHealth Technology Biosyntia ApS provides services in synthetic biology and metabolic engineering fields. It offers biocatalysts for fermentation of fine chemicals. The company was founded by Andreas Hougaard Laustsen, Morten Otto Alexander Sommer, and Hans Jasper Genee in 2012 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - |
Eerdere bekende functies van Sara Sande
Bedrijven | Functie | Einde |
---|---|---|
CooperSurgical, Inc.
CooperSurgical, Inc. Medical SpecialtiesHealth Technology CooperSurgical, Inc. develops, manufactures, and markets medical instruments. It offers surgical, clinical and practice based, labor and delivery and critical care. The firm’s surgical products include C-section retractors, hysterectomy/laparoscopic instruments and laparoscopic port-site closures. The company was founded in 1990 and is headquartered in Trumbull, CT. | Corporate Officer/Principal | - |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
HYDRACT A/S | Director/Board Member | - |
Opleiding van Sara Sande
University of Copenhagen | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
EXPRES2ION BIOTECH HOLDING AB | Health Technology |
HYDRACT A/S | Producer Manufacturing |
Bedrijven in privébezit | 4 |
---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark. | Process Industries |
CooperSurgical, Inc.
CooperSurgical, Inc. Medical SpecialtiesHealth Technology CooperSurgical, Inc. develops, manufactures, and markets medical instruments. It offers surgical, clinical and practice based, labor and delivery and critical care. The firm’s surgical products include C-section retractors, hysterectomy/laparoscopic instruments and laparoscopic port-site closures. The company was founded in 1990 and is headquartered in Trumbull, CT. | Health Technology |
Origio A/S
Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Health Technology |
Biosyntia ApS
Biosyntia ApS BiotechnologyHealth Technology Biosyntia ApS provides services in synthetic biology and metabolic engineering fields. It offers biocatalysts for fermentation of fine chemicals. The company was founded by Andreas Hougaard Laustsen, Morten Otto Alexander Sommer, and Hans Jasper Genee in 2012 and is headquartered in Copenhagen, Denmark. | Health Technology |